Form D · Other Health Care
National Toxicology LLC
Dallas, TX · CIK 0001546997
Offering snapshot reported Jun 1, 2012 · SEC filing
- Reported sold
- $181K Offering amount: $200K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $2.5K Reported outside-investor minimum
- First sale
- Mar 10, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 1, 2012 | Initial | $180,570 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-179164
Source: Form D, filed Jun 1, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Josh Daniel | Executive |
| Jeffrey Lawrence Wasserman | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
13601 Preston Rd Suite 220 E
Dallas, TX, 75240
Dallas, TX, 75240